S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Fund/Avoro Capital Advisors/Q2 2022

Avoro Capital Advisors

Periodo: Q2 2022 Β· Depositato: 2022-08-15
Vedi su SEC EDGAR β†—
AUM
$5.06B
Valore totale del portafoglio
Posizioni
40
Titoli dichiarati
Prima Posizione
UTHR
13.8% $699.9M
Var. Trimestrali
+1 / -4
nuovi Β· usciti
⚠️Informativa sui Depositi 13F

I dati AUM mostrati sono calcolati sommando il valore di mercato dichiarato di tutte le posizioni nei depositi SEC 13F-HR β€” non rappresentano il patrimonio effettivo gestito dal fondo.

  • Escluse liquiditΓ , obbligazioni, private equity, posizioni corte e azioni estere non soggette all'obbligo di dichiarazione.
  • Per le opzioni PUT e CALL, il Valore dichiarato Γ¨ il valore nozionale delle azioni sottostanti β€” non il premio pagato. CiΓ² sovrastima significativamente il capitale effettivamente a rischio.
  • Il patrimonio reale del fondo Γ¨ tipicamente superiore e include strategie, strumenti e posizioni che non compaiono mai in un 13F.
  • I depositi 13F riguardano i gestori istituzionali con β‰₯$100M in titoli 13F. Le posizioni riflettono le partecipazioni a fine trimestre, divulgate entro 45 giorni dalla fine del periodo.

Dati provenienti da SEC EDGAR. Questo tracker Γ¨ a scopo puramente informativo e non costituisce consulenza finanziaria.

Partecipazioni in Portafoglio

Prime 30 posizioni

⚠️ Performance % calcolata dalla data di deposito ( 2022-08-15) si riferisce al titolo sottostante β€” non al P&L del derivato.
TickerEmittenteNozionalePortafoglio %Al DepositoOra (Fine Giornata)Dal DepositoAllocazione
UTHRUNITED THERAPEUTICS CORP$699.9M13.83%$235.64$555.91+135.9%
13.8%
ARGXARGENX SE$479.5M9.48%$378.88$939.68+148.0%
9.5%
APLSAPELLIS PHARMACEUTICALS INC$443.4M8.76%$45.22β€”
8.8%
HZNPHORIZON THERAPEUTICS PLC$398.8M7.88%β€”β€”
7.9%
MRTXMIRATI THERAPEUTICS INC$372.6M7.36%β€”β€”
7.4%
FOLDAMICUS THERAPEUTICS INC$287.8M5.69%β€”β€”
5.7%
BMRNBIOMARIN PHARMACEUTICAL INC$272.1M5.38%$82.87$58.99-28.8%
5.4%
SGENSEAGEN INC$269.8M5.33%β€”β€”
5.3%
SRPTSAREPTA THERAPEUTICS INC$254.1M5.02%$74.96$19.28-74.3%
5.0%
ASNDASCENDIS PHARMA$211.5M4.18%$92.96$274.50+195.3%
4.2%
ALNYALNYLAM PHARMACEUTICALS INC$198.4M3.92%$145.85$312.78+114.5%
3.9%
XENEXENON PHARMACEUTICALS INC$149.1M2.95%$30.42$60.96+100.4%
3.0%
MDGLMADRIGAL PHARMACEUTICALS INC$109.9M2.17%$71.58$528.10+637.8%
2.2%
IOVAIOVANCE BIOTHERAPEUTICS INC$101.8M2.01%$11.04$4.31-61.0%
2.0%
KURAKURA ONCOLOGY INC$88.0M1.74%$18.33$11.10-39.4%
1.7%
KRYSKRYSTAL BIOTECH INC$70.6M1.39%$65.66$375.07+471.2%
1.4%
BCRXBIOCRYST PHARMACEUTICALS INC$68.8M1.36%$10.58$9.84-7.0%
1.4%
ISEEIVERIC BIO INC$68.5M1.35%β€”β€”
1.4%
XBISPDR SERIES TRUST - S&P BIOTECH$66.8M1.32%$73.80$160.46+117.4%
1.3%
RAREULTRAGENYX PHARMACEUTICAL INC$44.7M0.88%$59.66$33.47-43.9%
0.9%
PMVPPMV PHARMACEUTICALS INC$44.2M0.87%$14.25$1.22-91.4%
0.9%
SNDXSYNDAX PHARMACEUTICALS INC$42.8M0.84%$19.24$21.82+13.4%
0.8%
MRSNMERSANA THERAPEUTICS INC$34.9M0.69%β€”β€”
0.7%
MNKDMANNKIND CORP$34.7M0.69%$3.81$4.52+18.6%
0.7%
GLUEMONTE ROSA THERAPEUTICS INC$32.0M0.63%$9.67$24.21+150.4%
0.6%
DSGNDESIGN THERAPEUTICS INC$31.1M0.61%$14.00$15.64+11.7%
0.6%
CBAYCYMABAY THERAPEUTICS INC$30.4M0.60%β€”β€”
0.6%
KYMRKYMERA THERAPEUTICS INC$24.8M0.49%$19.69$113.51+476.5%
0.5%
WHWKAADI BIOSCIENCES INC$22.5M0.45%$12.32$4.19-66.0%
0.5%
RNAMAVIDITY BIOSCIENCES INC$18.9M0.37%β€”β€”
0.4%

AttivitΓ  Trimestre su Trimestre

Q2 2022 vs. Q1 2022

Nuove Posizioni (1)

TickerEmittenteNozionale
RLAYRELAY THERAPEUTICS INC$6.7M

Posizioni Chiuse (4)

TickerEmittenteNozionale
ACADACADIA PHARMACEUTICALS INC$55.1M
PRAXPRAXIS PRECISION MEDICINES INC$21.9M
AVDLXXXXAVADEL PHARMACEUTICALS PLC$11.4M
ADVMADVERUM BIOTECHNOLOGIES INC$9.1M

Aumentate (8)

TickerEmittenteNozionaleVar. AzioniDal Deposito
BCRXBIOCRYST PHARMACEUTICALS INC$38.3M+246.7%-7.0%
RAREULTRAGENYX PHARMACEUTICAL INC$28.0M+226.1%-43.9%
KYMRKYMERA THERAPEUTICS INC$-9.7M+54.3%+476.5%
PMVPPMV PHARMACEUTICALS INC$-1.6M+40.9%-91.4%
FOLDAMICUS THERAPEUTICS INC$93.7M+30.7%
SGENSEAGEN INC$80.4M+16.0%
MRSNMERSANA THERAPEUTICS INC$7.8M+11.0%
BMRNBIOMARIN PHARMACEUTICAL INC$38.1M+8.2%-28.8%

Ridotte (5)

TickerEmittenteNozionaleVar. AzioniDal Deposito
XBISPDR SERIES TRUST - S&P BIOTECH$-207.3M-70.5%+117.4%
HZNPHORIZON THERAPEUTICS PLC$-285.1M-23.1%
UTHRUNITED THERAPEUTICS CORP$156.2M-2.0%+135.9%
ISEEIVERIC BIO INC$-53.5M-1.8%
XENEXENON PHARMACEUTICALS INC$-3.3M-1.7%+100.4%
← Torna agli Hedge Fund